Effects of chitosan-carboxymethyl dextran nanoparticles on cell proliferation and on serum cytokine regulation

Journal of Biomedical Nanotechnology

Volumn 6, Issue 3, 2010, Pages 247-253

  Lin, Yi Sheng ^a   Okamoto, Yoshiharu ^b   Minami, Saburo ^b  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Chitosan; Cytokine; Cytotoxic; Nanoparticles; Proliferation

Indexed keywords

BIOMEDICAL MATERIAL; CYTOKINES; CYTOTOXIC; DEACETYLATION; DOSE-DEPENDENT MANNER; FIBROBLAST PROLIFERATION; IN-VITRO; IN-VIVO; MOUSE SERUM; MOUSE-FIBROBLASTS; PROLIFERATION; TUMOR CELLS;

ACETYLATION; BIOMEDICAL ENGINEERING; BODY FLUIDS; CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; MULTILAYERS; NANOPARTICLES;

CHITOSAN;

CARBOXYMETHYLDEXTRAN; CHITOSAN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NANOPARTICLE; DEXTRAN; DRUG CARRIER;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; CELL LINE; DRUG EFFECT; HELA CELL; MATERIALS TESTING; METABOLISM;

ANIMALS; CELL LINE; CELL PROLIFERATION; CHITOSAN; CYTOKINES; DEXTRANS; DRUG CARRIERS; FIBROBLASTS; HELA CELLS; HUMANS; MATERIALS TESTING; MICE; NANOPARTICLES;

EID: 79952201212     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.11/jbn.2010.1122     Document Type: Article

References (28)

1. T. Nagamoto, Y. Hattori, K. Takayama, and Y. Maitani, Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm. Res. 21, 671 (2004).
2. K. Nishimura, S. Nishimura, N. Nishi, I. Saiki, S. Tokura, and I. Azuma, Immunological activity of chitin and its derivatives. Vaccine 2, 93 (1984).
3. K. Nishimura, S. Nishimura, N. Nishi, F. Numata, Y. Tone, S. Tokura, and I. Azuma, Adjuvant activity of chitin derivatives in mice and guinea-pigs. Vaccine 3, 379 (1985).
4. K. Nishimura, C. Ishihara, S. Ukei, S. Tokura, and I. Azuma, Stimulation of cytokine production in mice using deacetylated chitin. Vaccine 4, 151 (1986).
5. A. Pattani, V. B. Patravale, L. Panicker, and P. D. Potdar, Immunological effects and membrane interactions of chitosan nanoparticles. Mol. Pharm. 6, 345 (2009).
6. J. Zhang, X. G. Chen, G. Z. Sun, L. Huang, and X. J. Cheng, Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin. Colloids Surf. B Biointerfaces 77, 125 (2010).
7. G. Gabbiani, The myofibroblast in wound healing and fibrocontractive Diseases. J. Pathol. 200, 500 (2003).
8. S. Minami, Y. Okamoto, and S. Tanioka, Carbohydrates and Carbohydrate Polymer, edited by M. Yalpani, ATL Press, Illinois (1993), pp. 159-163.
9. Z. Shi, K. G. Neoh, E. T. Kang, and W. Wang, Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 27, 2440 (2006).
10. L. Qi, Z. R. Xu, Y. Li, X. Jiang, and X. Y. Han, In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J. Gastroenterol. 11, 5136 (2005).
11. L. Qi, Z. R. Xu, and M. Chen, In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur. J. Cancer 43, 184 (2007).
12. D. R. Krause, T. J. Piva, S. B. Brown, and K. A. Ellem, Characterization and localization of mitochondrial oligopeptidase (MOP) (EC 3.4.24.16) activity in the human cervical adenocarcinoma cell line HeLa. J. Cell. Biochem. 66, 297 (1997).
13. R. K. Das, N. Kasoju, and U. Bora, Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6, 153 (2010).
14. D. W. Lee, K. S. Yun, H. S. Ban, W. Choe, S. K. Lee, and K. Y. Lee, Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J. Control Release 139, 146 (2009).
15. Y. S. Lin, E. Renbutsu, M. Morimoto, Y. Okamura, T. Tsuka, H. Saimoto, Y. Okamoto, and S. Minami, Preparation of stable chitosan-carboxymethyl dextran Nanoparticles. J. Nanosci. Nanotechnol. 9, 2558 (2009).
16. K. Wagner, A. Kautz, M. Roder, M. Schwalbe, K. Pachmann, and J. H. Clement, Synthesis of oligonucleotide-functionalized magnetic nanoparticles and study on their in vitro cell uptake. Appl. Organomet. Chem. 18, 514 (2004).
17. S. Hirano, Y. Ohe, and H. Ono, Selective N-acylation of chitosan. Carbohydr. Res. 47, 315 (1976).
18. M. Huang, E. Khor, and L. Y. Lim, Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm. Res. 21, 344 (2004).
19. Q. Gan, T. Wang, C. Cochrane, and P. McCarron, Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf. B Biointerfaces 44, 65 (2005).
20. G. I. Howling, P. W. Dettmar, P. A. Goddard, F. C. Hampson, M. Domish, and E. J. Wood, The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials 22, 2959 (2001).
21. R. J. Schmidt, L. Y. Chung, A. M. Andrews, O. Spyratou, and T. D. Turner, Biocompatibility of wound management products: A study of the effect of various polysaccharides on murine L929 fibroblast proliferation and macrophage respiratory burst. J. Pharm. Pharmacol. 45, 508 (1993).
22. C. Colonna, B. Conti, P. Perugini, F. Pavanetto, T. Modena, R. Dorad, P. Iadarola, and I. Genta, Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy. Eur. J. Pharm. Biopharm. 70, 58 (2008).
23. A. Nasti, N. M. Zaki, P. de Leonardis, S. Ungphaiboon, P. Sansongsak, M. G. Rimoli, and N. Tirelli, Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: Systematic optimisation of the preparative process and preliminary biological evaluation. Pharm. Res. 26, 1918 (2009).
24. L. Qi, Z. R. Xu, X. Jiang, Y. Li, and M. Wang, Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg. Med. Chem. Lett. 15, 1397 (2005).
25. Y. Shibata, L. A. Foster, W. J. Metzger, and Q. N. Myrvik, Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect. Immun. 65, 1734 (1997).
26. Y. Shibata, L. A. Foster, M. Kurimoto, H. Okamura, R. M. Nakamura, and K. Kawajiri, Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J. Immunol. 161, 4283 (1998).
27. M. J. McGeachy, K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, and T. McCIanahan, TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th-17 cell-mediated pathology. Nat. Immunol. 8, 1390 (2007).
28. K. H. Mills, Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 38, 2636 (2008).